A sensitive ELISA for glial fibrillary acidic protein: application in CSF of children. 1992

L E Rosengren, and G Ahlsén, and M Belfrage, and C Gillberg, and K G Haglid, and A Hamberger
Institute of Neurobiology, University of Göteborg, Sweden.

In the present study we describe a sensitive ELISA for determination of glial fibrillary acidic protein (GFAP). To validate the method combined determinations of GFAP and S-100 protein were performed in cerebrospinal fluid (CSF) of normal children and children with autism. The GFAP ELISA is of sandwich type and uses the biotin-avidin system. Sensitivity was 16 pg/ml. Between-day precision was 0.079 (coeff. of variance). S-100 protein concentrations were measured using a commercially available ELISA kit. Normal CSF from children and young adults were analysed. The CSF levels of GFAP in normal children were low (16-163 pg/ml). Both GFAP and S-100 protein concentrations correlated with age (P < 0.01 and P < 0.05, respectively), but the GFAP increment was more pronounced, probably reflecting the age-dependent expansion of the fibrillary astrocytes in the central nervous system (CNS). GFAP levels in children with infantile autism were higher than those in normal children of the same age range. S-100 protein concentrations were similar in both groups. High levels of GFAP in combination with normal S-100 protein concentrations in CSF indicates reactive astrogliosis in the CNS. In conclusion, the sensitive ELISA described makes it possible to measure low levels of GFAP present in the CSF of children. Combined assays of GFAP and S-100 protein can be used to discriminate between acute and chronic brain disorders in children.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D009418 S100 Proteins A family of highly acidic calcium-binding proteins found in large concentration in the brain and believed to be glial in origin. They are also found in other organs in the body. They have in common the EF-hand motif (EF HAND MOTIFS) found on a number of calcium binding proteins. The name of this family derives from the property of being soluble in a 100% saturated ammonium sulfate solution. Antigen S 100,Nerve Tissue Protein S 100,S100 Protein,S-100 Protein,S100 Protein Family,Protein, S100,S 100 Protein
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D005904 Glial Fibrillary Acidic Protein An intermediate filament protein found only in glial cells or cells of glial origin. MW 51,000. Glial Intermediate Filament Protein,Astroprotein,GFA-Protein,Glial Fibrillary Acid Protein,GFA Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

L E Rosengren, and G Ahlsén, and M Belfrage, and C Gillberg, and K G Haglid, and A Hamberger
March 1994, Journal of neuroscience methods,
L E Rosengren, and G Ahlsén, and M Belfrage, and C Gillberg, and K G Haglid, and A Hamberger
April 2004, Journal of immunological methods,
L E Rosengren, and G Ahlsén, and M Belfrage, and C Gillberg, and K G Haglid, and A Hamberger
April 1998, Neurology,
L E Rosengren, and G Ahlsén, and M Belfrage, and C Gillberg, and K G Haglid, and A Hamberger
September 1991, Presse medicale (Paris, France : 1983),
L E Rosengren, and G Ahlsén, and M Belfrage, and C Gillberg, and K G Haglid, and A Hamberger
January 1981, Acta neuropathologica,
L E Rosengren, and G Ahlsén, and M Belfrage, and C Gillberg, and K G Haglid, and A Hamberger
January 1985, Acta neuropathologica,
L E Rosengren, and G Ahlsén, and M Belfrage, and C Gillberg, and K G Haglid, and A Hamberger
May 2002, Current protocols in toxicology,
L E Rosengren, and G Ahlsén, and M Belfrage, and C Gillberg, and K G Haglid, and A Hamberger
January 2022, European journal of medical research,
L E Rosengren, and G Ahlsén, and M Belfrage, and C Gillberg, and K G Haglid, and A Hamberger
January 1989, Acta neuropathologica,
L E Rosengren, and G Ahlsén, and M Belfrage, and C Gillberg, and K G Haglid, and A Hamberger
June 2019, Current opinion in neurology,
Copied contents to your clipboard!